Removing the IPMK gene from intestinal cells in mice reduces a specific molecule called InsP6, which alters chemical modifications on DNA, increases the production of enzymes that break down tissue,...

We analyzed the available evidence and found that deleting the IPMK gene in mouse intestinal cells is linked to a drop in InsP6, a molecule involved in cellular signaling. This reduction appears to change how DNA is chemically marked, which may influence gene activity. Along with this, we saw an increase in enzymes that break down tissue structures and a weakening of the intestinal barrier — the lining that helps control what passes from the gut into the body [1]. The evidence we’ve reviewed so far comes from eight supporting assertions, with no studies contradicting this pattern. These findings suggest that IPMK plays a role in maintaining the integrity of the intestinal lining in mice, possibly through its effect on InsP6 and downstream molecular changes. However, we cannot say whether this happens the same way in humans, or what long-term effects this might have beyond what was observed in these studies. The intestinal barrier acts like a selective filter — it lets nutrients in while keeping harmful substances out. When it weakens, it may allow things that shouldn’t enter the bloodstream to pass through. While this observation is consistent across the studies we’ve reviewed, we don’t yet know if this leads to inflammation, disease, or other health outcomes in the mice. What we’ve found so far points to a clear biological connection between IPMK deletion and changes in the gut lining, but more research would be needed to understand the full picture. For now, this remains a finding in mice, and we don’t know how it translates to human biology.